title: Postoperative transarterial chemoembolization benefits patients with high γ-glutamyl transferase levels after curative hepatectomy for hepatocellular carcinoma: a survival stratification analysis.
abstract: Hepatocellular carcinoma (HCC) is the most common liver tumor in Asian countries, and hepatectomy is currently regarded as the optimal curative treatment for HCC; however, the postoperative outcome remains unsatisfactory.  Aiming at further clarification of prognostic factors after hepatectomy, we adopted a detailed stratification on survival periods.  A total of 428 HCC patients undergoing curative hepatectomy were firstly divided into two groups using 2-year survival as cutoff point.  Multivariate analysis showed that tumor-related factors, including vascular invasion (P < 0.001), high Edmondson grade (P < 0.001), large tumor size (P < 0.001) and high serum alpha-fetoprotein level (P = 0.001), were significant determinants for early death within 2 years, while postoperative transarterial chemoembolization (TACE) was demonstrated a protective factor (P = 0.013).  Then the 281 patients with survival > 2 years were divided into two subgroups according to survival or death during follow-up to examine the late death related factors.  We found that high serum γ-glutamyl transpeptidase (GGT), indicating severity of underlying liver disease, was significantly linked to death in this stage (P = 0.006).  In further comparison of survival rates between subgroups stratified by early- and late-death indictors, we found the long-term outcomes of patients with high serum GGT were poor, regardless of the factors related with primary tumor.  Furthermore, postoperative TACE decreased late death rate of patients with high GGT levels.  In conclusion, despite the overwhelmed effects of primary tumor in the early stage after hepatectomy, postoperative TACE is beneficial for HCC patients with poor liver status.
authors: The Hospital & Institute of Hepatobiliary Surgery, Chinese PLA General Hospital, Beijing, PR China.
authors: Hansheng
authors: H
authors: Liu
authors: Aiqun
authors: A
authors: Zhang
authors: Niansong
authors: N
authors: Qian
authors: Lijie
authors: L
authors: Gao
authors: Lining
authors: L
authors: Xu
authors: Wenzhi
authors: W
authors: Zhang
authors: Kai
authors: K
authors: Jiang
authors: Shouwang
authors: S
authors: Cai
authors: Zhiqiang
authors: Z
authors: Huang
authors: Jiahong
authors: J
authors: Dong
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000097:blood* / Q000201:enzymology / Q000401:mortality / Q000601:surgery*; D016461:Chemoembolization, Therapeutic; D002681:China / Q000453:epidemiology; D005260:Female; D006498:Hepatectomy; D006801:Humans; D053208:Kaplan-Meier Estimate; D008113:Liver Neoplasms / Q000097:blood* / Q000201:enzymology / Q000401:mortality / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011182:Postoperative Care; D012307:Risk Factors; D016019:Survival Analysis; D015996:Survival Rate; D013997:Time Factors; D005723:gamma-Glutamyltransferase / Q000097:blood*
chemical_list: D005723:gamma-Glutamyltransferase